Bio Usawa becomes partner for the commercialization of FYB201/ BioUcenta™ (ranibizumab) across Sub-Saharan Africa
Formycon AG / Key word(s): Alliance/Market Launch
01.07.2025 / 13:15 CET/CEST
The issuer is solely responsible for the content of this announcement.
01.07.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News – a service of EQS Group.
The issuer is solely responsible for the content of this announcement.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at http://www.eqs-news.com
This news is powered by Ad Hoc News 
